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Erlangen, GermanyABSTRACT The slow delayed rectifier (IKs) channel is composed of the KCNQ1 channel and KCNE1 auxiliary subunit, and
functions to repolarize action potentials in the human heart. IKs activators may provide therapeutic efficacy for treating long
QT syndromes. Here, we show that a new KCNQ1 activator, ML277, can enhance IKs amplitude in adult guinea pig and canine
ventricular myocytes. We probe its binding site and mechanism of action by computational analysis based on our recently re-
ported KCNQ1 and KCNQ1/KCNE1 3Dmodels, followed by experimental validation. Results from a pocket analysis and docking
exercise suggest that ML277 binds to a side pocket in KCNQ1 and the KCNE1-free side pocket of KCNQ1/KCNE1. Molecular-
dynamics (MD) simulations based on the most favorable channel/ML277 docking configurations reveal a well-defined ML277
binding space surrounded by the S2-S3 loop and S4-S5 helix on the intracellular side, and by S4–S6 transmembrane helices
on the lateral sides. A detailed analysis of MD trajectories suggests two mechanisms of ML277 action. First, ML277 restricts
the conformational dynamics of the KCNQ1 pore, optimizing Kþ ion coordination in the selectivity filter and increasing current
amplitudes. Second, ML277 binding induces global motions in the channel, including regions critical for KCNQ1 gating transi-
tions. We conclude that ML277 activates IKs by binding to an intersubunit space and allosterically influencing pore conductance
and gating transitions. KCNE1 association protects KCNQ1 from an arrhythmogenic (constitutive current-inducing) effect of
ML277, but does not preclude its current-enhancing effect.INTRODUCTIONThe slow delayed rectifier (IKs) channel is composed of two
main components: the KCNQ1 channel and the KCNE1
auxiliary subunit (1) (abbreviated as Q1 and E1, respec-
tively). IKs functions as a repolarization reserve in the hu-
man heart, i.e., it helps to limit action potential durations
(APDs) under stressful conditions, when the b-adrenergic
tone is high or when other repolarizing currents are sup-
pressed (2,3).
In recent years, there has been an increasing interest in
developing Kv channel activators as therapeutic agents
(4,5). In the cardiac field, the most important application
is to treat acquired and congenital long QT (LQT) syn-
dromes. Several Q1 activators are available, but they are
limited by a lack of specificity (zinc pyrithione (ZnPy) acti-
vates not only Q1 but also other members of the KCNQ fam-
ily, which are important in regulating neuronal excitability
(4)) or low potency (phenylboronic acid increases recombi-
nant IKs with an EC50 of 1.6 mM (6)). In 2012, a new Q1
activator, ML277 (ML), was identified (7). ML is selective
for Q1 (R100-fold more potent in activating Q1 than
KCNQ2 or KCNQ4) and highly potent (EC50 < 1 mM) (7).Submitted August 21, 2014, and accepted for publication October 27, 2014.
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0006-3495/15/01/0062/14 $2.00A previous report showed that ML is active on unsaturated
IKs channels, i.e., (Q1)4/(E1)n, with n< 4 (8). Increasing the
expression level of E1 eventually abolished ML’s activity.
ML was active on native IKs expressed in immature cardiac
myocytes derived from human induced pluripotent stem cells
(8). Is ML active on IKs in adult ventricular myocytes? In this
study, we address that question and several others: Where is
the binding site of ML in the Q1 channel? What is the mech-
anism ofML action on the Q1 channel? How does E1 associ-
ation with Q1 impact the binding andmechanism of action of
ML? To avoid the pitfalls of a candidate binding site search,
our approach begins with an in silico search for potential
ligand-binding pockets in Q1 and Q1/E1 models. Detailed
3D structures of Q1 and Q1/E1 are a prerequisite for this
approach. We recently developed such 3D models of Q1
and Q1/E1 (9) based on the Kv channel crystal structure
(Protein Data Bank [PDB] ID: 2R9R) (10) and E1 NMR
structure (PDB ID: 2K21) (11), after computational refine-
ment to correct nonnative conformations in loop regions).
Unique among currently available Q1/E1 models (11–13),
our model includes the complete N-terminal domain of E1
(aa 1–43). Importantly, we have experimentally validated
extensive interactions between this E1 domain and the extra-
cellular linkers of Q1 (9).
Our results suggest that ML binds to a side pocket in Q1
and in the E1-free cleft space of Q1/E1. We provide modelhttp://dx.doi.org/10.1016/j.bpj.2014.10.059
Allostery of ML277’s Action on IKs 63predictions and experimental validation for how ML in-
creases the Q1 current amplitude and how E1 association
impacts ML’s activator effect.MATERIALS AND METHODS
Computational modeling and analysis
We used the Computed Atlas of Surface Topography of Proteins (CASTp)
server (14) to perform a global search for ligand-binding pockets in the Q1
and Q1/E1 models. The ML structure was optimized by Gaussian 03 (http://
www.gaussian.com). We then used AutoDock 4.2 (15) to dock ML to the
Q1 and Q1/E1 models. Molecular dynamics (MD) simulations were done
using GROMACS v4.5.3 with the GROMOS96 53a6 force field (16).Molecular biology
Site-directed mutagenesis of Q1 was done using the QuikChange mutagen-
esis kit (Invitrogen). For oocyte expression, cRNA was prepared with the
use of an in vitro transcription kit (Mmessage Mmachine, Ambion, TX).COS-7 expression and perforated patch clamp
experiments
Culture and cDNA transfection of COS-7 cells were performed as described
previously (3). Whole-cell currents were recorded using the perforated
patch clamp configuration with an AxoPatch 200B amplifier at room tem-
perature. Patch clamp experiments were controlled by Clampex of the
pClamp10 program suite via DigiData 1440A.Oocyte preparation and two-electrode voltage
clamp experiments
Oocyte preparation, cRNA injection, and voltage clamping were done as
described previously (17). Whole-oocyte currents were recorded using
the two-electrode voltage clamp configuration with an OC725D amplifier
at room temperature. Voltage-clamp experiments were controlled in the
same manner as described above.Cardiac myocyte isolation and perforated patch
clamp experiments
Ventricular myocytes were isolated from guinea pig and canine hearts
as described previously (18,19). The perforated patch clamp conditions
were similar to those described for the COS-7 experiments. All recordings
were done at 34 5 1C. APs were recorded in normal Tyrode’s solution
without any blockers. During IKs recording, myocytes were exposed to
4AP (3 mM), CdCl2 (0.3 mM), and dofetilide (0.5 mM) to suppress Ito,
INa, and ICaL and IKr.
Details regarding the computational modeling, MD simulations, and
experimental procedures are provided in the Supporting Material.RESULTS AND DISCUSSION
ML277 increases native IKs amplitude in adult
ventricular myocytes and works from inside the
cell membrane
We tested the effect of ML277 (ML, 1 mM) on native IKs
of adult guinea pig and canine ventricular myocytes (Fig. 1,A–C, left panels, and Fig. S1 A). Dofetilide (0.5 mM) was
used to block IKr, andwe confirmed that the current enhanced
by ML was suppressed by an IKs blocker, HMR1556. ML
increased the IKs amplitudes (by 22% 5 5% and 228% 5
105% in guinea pig and canine myocytes, respectively),
and shortened the action potential duration (APD). ML had
little effect on the L-type Ca current (ICaL) or the inward-
rectifying current (IK1) (Fig. S1 B), which are important in
determining the APD in ventricular myocytes. Together,
these observations indicate that native IKs channels in adult
ventricular myocytes are not saturated with E1, i.e., the IKs
channels have fewer than four E1 subunits per Q1 tetramer
channel (8), which allows ML to exert its activator effect.
Therewere species variations in howML affected the voltage
dependence of IKs activation: it shifted the half-maximum IKs
activation voltage in the depolarizing direction by 30 5
11 mV in canine ventricular myocytes, but did not shift the
IKs activation curve in guinea pig ventricular myocytes.
Similar to the observations for native IKs in guinea pig
ventricular myocytes, ML (1 mM) increased the current
amplitude of recombinant IKs (human Q1 and E1 coex-
pressed in COS-7 cells, with a cDNA molar ratio of 1:1)
by 28% 5 10%, without shifting the voltage dependence
of activation (Fig. 1, A and B, middle panels). On the other
hand, when the human Q1 was expressed alone, ML not
only increased the current amplitude (by 183% 5 89%)
but also altered the gating kinetics: it shifted the half-
maximum activation voltage in the hyperpolarizing direc-
tion by 23.9 5 6.3 mV, greatly slowed the deactivation
rate, and induced an apparent constitutive current compo-
nent (Fig. 1, A and B, right panels). This ML-induced
apparent constitutive component is similar to the gain-of-
function phenotype of Q1 mutants associated with short
QT syndrome and familial atrial fibrillation (20,21). There-
fore, E1 association with Q1 prevented this arrhythmogenic
(constitutive current-inducing) effect of ML, without abol-
ishing its current-enhancing effect.
Before we began an in silico search for the ML binding
sites in Q1 and Q1/E1, we needed to know from which
side of the cell membrane ML accesses its binding sites.
ML added to the bath solution increased native IKs over
a time course of 15–20 min (Fig. 1 C, middle panel, and
Fig. S1 Aa). Washing out ML for 20 min led to only an
incomplete reversal of its activator effect. These observa-
tions suggest that ML might need to permeate through the
cell membrane to act on the IKs channels from inside. We
tested the sidedness of ML action on Q1 expressed in oo-
cytes by intra-oocyte injection (n ¼ 3; for an example, see
Fig. 1 C, right panel). We injected 30 nl of ML solution
to reach an estimated cytoplasmic concentration of
60 mM. This caused a rapid increase in the Q1 current ampli-
tude. Subsequent injection of the same volume of tetrae-
thylammonium (TEA) solution, reaching an estimated
cytoplasmic concentration of 2 mM, caused a rapid decrease
in the Q1 current amplitude. The TEA effect indicated thatBiophysical Journal 108(1) 62–75
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FIGURE 1 ML277 (ML) increases native IKs
amplitude in adult ventricular myocytes and works
from inside the cell membrane. (A) Tail I-V rela-
tionships of IKs in guinea pig ventricular myocyte,
KCNQ1/KCNE1 (Q1/E1), or KCNQ1 (Q1 alone)
expressed in COS-7 cells before and after applica-
tion of ML (1 mM). Inset: voltage-clamp protocol.
The open arrow in the right panel of A points to
the apparent constitutive current component. (B)
Normalized tail I-V relationships from the same
cells shown in A. For each cell, the relationship be-
tween tail current (Itail) and test pulse voltage (Vt)
was fit with a simple Boltzmann function, Itail ¼
Imax/(1 þ exp((V0.5  Vt)/k)), to estimate the
maximal tail current (Imax), half-maximum activa-
tion voltage (V0.5), and slope factor (k). The frac-
tion activated (¼ Itail/Imax) is plotted against Vt,
superimposed on a curve calculated from the Boltz-
mann function. Insets: current traces before and af-
ter application of ML with Vh, Vt, and Vr marked.
(C) Left: 1 mM ML shortened the APD of a guinea
pig ventricular myocyte. Inset: ML structure.
Middle: time course of changes in IKs amplitude
in a guinea pig ventricular myocyte before, dur-
ing, and after application of ML, followed by
HMR1556 (HMR). Right: time course of changes
in Q1 current amplitude expressed in an oocyte
before and after intra-oocyte injection of ML, fol-
lowed by TEA injection (estimated cytoplasmic
concentrations based on assumed oocyte volume
of 0.5 ml). Insets: current traces from time points
marked by asterisks in the time courses. The
following color scheme is used for all panels:
gray, control; black, ML; dark gray, HMR
or TEA. Light-gray shading in this and subse-
quent figures marks the time point of current
measurement.
64 Xu et al.the ML-injection-induced increase in Q1 current amplitude
was not due to a cell-swelling artifact. We conclude that ML
accesses its binding site in the Q1 and Q1/E1 channels from
the intracellular side of the cell membrane.Search for ML binding sites in KCNQ1 and
KCNQ1/KCNE1
We used the CASTp server (14) to search for ligand-binding
pockets in the channel models. The program identified more
than 200 ligand-binding pockets each in Q1 and Q1/E1. We
ruled out those pockets at the external pore entrance and in
the central cavity because these locations are involved in
channel blockade. The remaining pockets were clustered
into five major locations (Fig. S2 A). Because ML accesses
its binding site from the intracellular side of the membrane,
we further ruled out the two pockets that were accessible
only to the extracellular solution, and focused on the re-
maining three pockets that were accessible to the intracel-
lular solution.
We used AutoDock to dock ML to the Q1 and Q1/E1
models (Fig. S2 B). The docking box (size: 36  36 
28 A˚) was placed in the Q1 model at the geometric centerBiophysical Journal 108(1) 62–75of the three putative ligand-binding pockets described
above. Our Q1/E1 model has two E1 subunits located at di-
agonal cleft spaces between Q1 subunits (9). We docked ML
to Q1/E1 in two configurations: in the E1-free cleft space
and in the E1-occupied cleft space. Fig. 2 A depicts the
100 top-ranking ML docking poses in each of the three sys-
tems. When ML was docked to Q1 or the E1-free cleft space
of Q1/E1, the binding poses could be divided into regions 1
and 2 (R1 and R2). R1 was a peripheral site at the intracel-
lular boundary of the S2-S3 loop and S4-S5 linker, and R2
was a pocket between the S5 and S6 helices. This distribu-
tion pattern suggests that ML accesses R1 from the intra-
cellular solution and then moves onto R2. When ML was
docked to the E1-occupied cleft space of Q1/E1, the binding
poses were limited to the pocket in R2. There was no ML in
the peripheral R1 site.Test model prediction 1: the number of ML
binding sites in KCNQ1 and KCNQ1/KCNE1
Since ML accesses R2 via R1, the lack of ML in the R1
location when docked to the E1-occupied cleft space sug-
gested that E1 prevented ML access to its binding sites.
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FIGURE 2 Docking ML to the Q1 and Q1/E1 models, and MD simulations. (A) Top 100 ML binding poses in Q1 (left), the E1-free cleft space of Q1/E1
(middle), and the E1-occupied cleft space of Q1/E1 (right). Q1 and E1 are shown as gray and purple ribbons, respectively. ML molecules are shown in
rainbow colors. R1 and R2 demarcate binding regions 1 and 2. (B and C) 3D plots of the center of mass of ML molecules, with x-y plane projections, during
100 ns MD simulations. Four ML molecules were docked to Q1 in R1 or R2 (Q1_ML_R1 and Q1_ML_R2), and two ML molecules were docked to the
equivalent positions in the E1-free cleft space of Q1/E1 (Q1/E1_ML_R1 and Q1/E1_ML_R2). The x and y axes are parallel and the z axis is normal to
the plane of lipid bilayer. (D) RMSD of Q1 Ca atoms (top) and all-atoms of ML during MD trajectories. The same color scheme for ML molecules is
used in B–D.
Allostery of ML277’s Action on IKs 65This led to the first model prediction: each Q1 channel has
four equivalent ML binding sites in the space between Q1
subunits, and the Q1/E1 channel has fewer than four ML
binding sites, the number of which depends on the number
of E1 subunits present. To test this prediction, we con-
structed concentration-response relationships between ML
concentrations and the resulting increase in the current am-
plitudes of Q1 and Q1/E1 (Fig. 3 A). We fit the concentra-
tion-response relationships with a modified Hill equation
(Fig. 3 B). If there are multiple ML binding sites and there
is strong cooperativity among the binding sites (i.e., binding
of the first ML molecule facilitates binding of subsequentML molecules, so that the binding sites are either free or
occupied), the Hill coefficient (nH) will approach the num-
ber of binding sites (22). For Q1 expressed in oocytes, the
average nH value was 3.85 0.2, supporting the model pre-
diction of four ML binding sites per Q1 channel and sug-
gesting a strong cooperativity among the four binding
sites. For Q1 expressed in COS-7 cells, the average nH value
was 2.15 0.3. Importantly, the nH value was only 1.25 0.2
for Q1/E1 expressed in COS-7 cells, about half of the nH
value of Q1 in the same expression system. These data sup-
port the notion that there are up to four ML binding sites in
the Q1 channel, but fewer in Q1/E1 because E1 prevents MLBiophysical Journal 108(1) 62–75
AB
FIGURE 3 Up to 4 ML binding sites per Q1 channel, but fewer ML binding sites in Q1/E1. (A) Top: superimposed current traces from Q1 and Q1/E1
expressed in COS-7 cells, and Q1 expressed in oocytes, elicited by the voltage-clamp protocols diagrammed in the insets, under control conditions, and
the steady-state effects of increasing concentrations of ML. Current amplitudes were measured at the end of the tail currents (open arrows). Bottom: ratio
of current amplitude in the presence of ML to control (IML/IC) plotted against ML concentrations ([ML], logarithmic scale) from the same cells as shown on
top. Current traces and data points are coded according to the color scheme shown on the right. (B) Left: data summary. For each cell, response to ML was
normalized to between 0 (control) and 1 (maximalML effect, 10 mM in COS-7 expression and 50 mM in oocyte expression), and averaged over cells (n¼ 5, 3,
4, respectively). The values of fraction of maximum effect are plotted against [ML] superimposed on curves calculated from the modified Hill equation (top
right). Bottom right: parameter values for the Hill equation.
66 Xu et al.from accessing its binding site. There was also an increase in
the EC50 value in Q1/E1 relative to Q1 (1.49 5 0.05 vs.
0.255 0.03 mM). The high EC50 for ML effects on Q1 ex-
pressed in oocytes (11.65 0.5 mM) is likely due to the fact
that the yolk is a sink of cytoplasmic ML molecules.Probing the ML binding sites in KCNQ1 and
KCNQ1/KCNE1 by MD simulations
AutoDock treated ML as a flexible molecule, but treated
proteins as rigid bodies. To probe how ML and Q1 interact
with each other when both are free to move, we subjected
the most favorable docking poses (based on the AutoDockBiophysical Journal 108(1) 62–75ranking) to MD simulations. ML molecules were placed
in the four equivalent R1 or R2 positions of Q1 (the config-
urations are termed Q1_ML_R1 and Q1_ML_R2 in the
following text), or in the two equivalent R1 or R2 positions
in the E1-free cleft space of Q1/E1 (configurations termed
Q1/E1_ML_R1 and Q1/E1_ML_R2). These initial configu-
rations are shown in Fig. S2 C. Each MD simulation lasted
100 ns, during which time the ML molecules actively
sampled the cleft space between Q1 subunits (shown by
the movements of the center of mass of ML molecules in
Fig. 2, B and C). The ML molecules moved more along
the z-axis (normal to the plane of lipid bilayer) than in the
x-y plane (parallel to the plane of the lipid bilayer),
Allostery of ML277’s Action on IKs 67reflecting the shape of the cleft space. Fig. 2D shows the tra-
jectories of the root mean-square deviation (RMSD) of Q1
Ca atoms and all-atoms of ML molecules. Except for Q1/
E1_ML_R2, the RMSD values reached equilibrium by
50 ns. In the following analysis of MD trajectories, we
focused on the 50–100 ns period.
We quantified the degree of contact between ML and Q1
during MD trajectories (for details of the data analysis, see
the Supporting Material). With Q1_ML_R1 as the initial
configuration, ML mainly interacted with the S2-S3 loop
and the S4-S5 linker (Fig. S3 A, first panel). With
Q1_ML_R2 as the initial configuration, ML interacted not
only with the S2-S3 loop and S4-S5 linker, but also with
the S5 and S6 helices (Fig. S3 A, second panel). We summed
the two sets of data, generating the degree of ML contacts
with Q1 shown in Fig. 4 A, top panel. A closer inspection
of Fig. S3 B reveals a helical periodicity in the pattern of
contacts between ML and the S3, S4, S4-S5, S5, and S6 he-
lices, indicating that ML made frequent contacts with one
face of each of these helices.A
B
FIGURE 4 Model prediction of ML binding space in the Q1 and Q1/E1 mod
docked to Q1 (top) or E1-free space of Q1/E1 (bottom). Calculation of the degr
porting Material. Transmembrane segments (S1–S6) and the pore (P) loop are h
experiments are marked along the abscissa. (B) Three views of an ML binding
involved in ML binding are shown (S2–S5 of one subunit (light gray ribbons) a
surface represents Q1 residues predicted to interact with bound ML molecules. E
3D view of the ML binding space in the context of the complete Q1 homologyA distinct ML binding space in the Q1 model emerged.
Fig. 4 B depicts three views of this ML binding space. Q1
residues making contact with ML are shown as a semitrans-
parent surface. Eleven ML docking poses are included to
illustrate the passage of MLmolecules from the intracellular
space to R1 and then R2. Movie S1 provides a 3D view of
the ML binding space in the context of the complete Q1
homology model. At the R1 site, ML engaged in p-cation
interactions with R195, R243, and R249, and p-p interac-
tions with F256. The R2 site is hydrophobic, where ML
engaged in p-p interactions with F275, F332, F335, and
F339. There were also hydrophobic interactions between
ML and Leu and Ile side chains at both the R1 and R2 sites
(details in Fig. S3 B).
The bottom two panels of Fig. S3 A show the patterns
of ML contacts with Q1 in the E1-free cleft space
with the initial configurations of Q1/E1_ML_R1 and Q1/
E1_ML_R2. These two patterns overlap little, indicating
more restricted ML movements in the cleft space of Q1/
E1 than in Q1. We summed the two sets of data and plotels. (A) Degree of ML contacts with Q1 during MD trajectories, with ML
ee of contacts (expressed in arbitrary units (A.U.)) is described in the Sup-
ighlighted by gray shading. Q1 residues tested in subsequent mutagenesis
space in the Q1 model. For clarity, only helices and loops that are directly
nd S5-S6 of the adjacent subunit (dark gray ribbons)). The semitransparent
leven ML binding poses are included for illustration. Movie S1 provides a
model.
Biophysical Journal 108(1) 62–75
68 Xu et al.the results in the lower panel of Fig. 4 A (degree of ML
contacts with Q1 in the E1-free clef space). The summed
patterns of the ML/Q1 contacts are similar between Q1
and Q1/E1, including the helical periodicity of ML contacts
with a similar set of Q1 residues on the S3, S4, S4-S5, S5,
and S6 helices (Fig. S3 B).Test model prediction 2: interactions between ML
and specific KCNQ1 side chains
The above results led to the second model prediction:
ML makes contacts with the Q1 residues highlighted in
Fig. S3 B. To test this prediction, we selected the following
side chains for mutation: R195 (S2-S3 loop), R243, and
R249 (S4-S5 linker). These side chains are important for
MLbinding to R1 byp-cation interactions.Wemutated these
Arg to Gln, preserving the side-chain volume and hydrophi-
licity, but not the charge. F275 (S5), F332, F335, and F339
(S6) engage in p-p interactions with ML in R2. We mutated
these Phe to Ala, preserving the hydrophobicity but not
the aromatic ring. Mutants were expressed in COS-7 cells.
Fig. S4 and Table S1 show that the mutations per se had
only modest effects on the Q1 gating kinetics and Q1 modu-
lation by E1, supporting the notion that these mutations did
not induce gross conformational changes in the Q1 channel.
Therefore, perturbations of ML’s effect, when observed,
likely resulted from local changes in the interaction betweenA
B
FIGURE 5 Impact of mutating Q1 side chains predicted to interact with bound
traces of Q1-WT and mutants expressed alone (top) or coexpressed with E1 (bot
1 mM ML (gray and black traces, respectively). Left inset: voltage-clamp proto
from Q1-WT are marked by gray-black histogram bars.
Biophysical Journal 108(1) 62–75ML and the mutated Q1 side chains. We then tested the
effects of 1 mM ML (the concentration that caused the
maximum effect on Q1-WT; Fig. 3) on these Q1 variants.
The top panel of Fig. 5 A depicts the original current traces
recorded before and after the application of ML. These cur-
rents were elicited by test pulses to the plateau voltages
of the respective activation curves before and afterML appli-
cation (Fig. S5). The top panel of Fig. 5 B summarizes the
ML-induced increases in the current amplitude (in %). Six
of the seven mutants significantly reduced the current-
enhancing effect of ML. The only exception was F339A,
which manifested an inactivation during depolarization
(Fig. 5 A, top right). ML removed the inactivation phase,
leading to an increase in the current amplitude that was
similar in degree to what was seen in Q1-WT. We conclude
that these data support the second model prediction.
ML docked to either R1 or R2made frequent contacts with
the S2-S3 loop and S4-S5 linker (Fig. S3 A, top two panels).
Therefore, with an ML molecule docked to R2, it would
engage key residues here (e.g., R195, R243, R249, and
F256) in p-cation and p–p interactions. Under these condi-
tions, even if anotherMLmolecule could reachR1, the newly
arrived drugmolecule could not be stabilized byp-cation and
p–p interactions with S2-S3 loop or S4-S5 linker. Therefore,
we propose that ML can bind to R1 or R2, but not both.
Although R195Q, R249Q, F275A, and F335A suppressed
the current-enhancing effect of ML, they did not preventMLmolecule on ML’s current-enhancing effect. (A) Representative current
tom) in COS-7 cells, under control conditions and the steady-state effects of
col. Vt is marked in each panel. (B) Data summary. Mutant data that differ
Allostery of ML277’s Action on IKs 69ML’s gating-modifying effect (slowing of deactivation;
Fig. 5 A, top panel). Thus, ML’s current-enhancing effect
can be dissociated from its gating-modifying effect, sug-
gesting two separate mechanisms. Furthermore, these muta-
tions disrupted the ability of ML binding to increase the Q1
current amplitude, without disrupting ML binding to the Q1
channel, i.e., ML increased the Q1 current amplitude by an
allosteric mechanism.
Whenwe tested themutants on theQ1variants coexpressed
with E1, we found that R195, F275A, F332A, and F335A
reduced ML’s current-enhancing effect, but F339A did not
(Fig. 5, A and B, lower panels). These effects are similar to
those observed in the absence of E1. However, the two muta-
tions in the S4-S5 linker, R243Q and R249Q, did not suppress
ML’s current-enhancing effect on Q1/E1. In fact, R243Q
enhanced ML’s activator effect in the presence of E1. These
observations suggest that E1 residing in the neighboring
cleft space could impact the transmission of signal from ML
binding to the pore conductance in these two mutants.Test model prediction 3: phosphatidylinositol-
4,5-bisphosphate and ML binding sites overlap
It has been suggested that R195, R243, and R249 are
involved in phosphatidylinositol-4,5-bisphosphate (PIP2)A B
C
FIGURE 6 ML and PIP2 binding sites overlap and the cell membrane PIP2 lev
PIP2 binding poses (eight in stick format with rainbow colors, and 92 as semitra
ML binding poses in R1, and the 100 PIP2 poses as semitransparent structures (e
recorded from Q1 alone or coexpressed with ci-VSP in oocytes, elicited by the d
presence of 50 mMML (black and red traces, respectively). Bottom: test pulse I
Comparison of IML/IC without versus with ci-VSP coexpression. Q1 current am
to þ60 mV.binding to the Q1 channel, either by directly forming salt-
bridges with the PIP2 headgroup or by playing an auxiliary
role (23). We used AutoDock to dock PIP2 to the Q1 model,
based on proposed PIP2 binding sites in Q1 (23) and Kv1.2
(24). Fig. 6 A (top panel) depicts the 100 top-ranking PIP2
binding poses in the Q1 model. PIP2 clashes with ML bound
at R1 (Fig. 6 A, bottom panel). This led to the third pre-
diction of our model: ML and PIP2 binding sites overlap
in the Q1 channel, and PIP2 impedes ML binding. To test
this model prediction, we coexpressed a voltage-activatable
phosphatase, Ciona intestinalis voltage sensor-containing
phosphatase (ci-VSP) (25), with Q1 in oocytes. Depolariza-
tion to >0 mV can activate the phosphatase of ci-VSP,
causing a time- and voltage-dependent decrease in the
PIP2 level in cell membrane (25). In oocytes coexpressing
Q1 and ci-VSP, the decrease in the membrane PIP2 level
was reflected by the time-dependent decline in the Q1 cur-
rent amplitude at þ60 mV and the decrease in test pulse
currents at >0 mV (Fig. 6 B, top and bottom panels).
Fig. 6 C shows that ci-VSP coexpression significantly
increased the ML’s activator effect on Q1. These observa-
tions thus support the third model prediction.
A recent study reported novel PIP2 binding sites in the Q1
channel (26): R190, R192 (S2-S3 loop), R249, R259 (S4-S5
linker), and K354 (post-S6). These Q1 residues interactedel affects ML potency. (A) Top: side view of Q1 homology model with 100
nsparent structures). Bottom: the same view of Q1 with eight representative
nlarged view in the yellow box). (B and C) Top: superimposed current traces
iagrammed voltage-clamp protocol under the control conditions and in the
-Vs from the same oocytes under control conditions and in 50 mMML. (D)
plitudes were measured as peak tail currents at 40 mV after 2 s pulses
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70 Xu et al.with ML molecules during MD trajectories (Fig. S3 B), sup-
porting the notion that ML and PIP2 compete for Q1 binding
sites.Probing the structural basis for ML’s action:
current enhancement
The above observations suggest that ML approaches the Q1
channel from the intracellular side of the membrane, inter-
acting with the S2-S3 loop and S4-S5 linker first, and then
moving onto a side pocket and interacting with the S5 and
S6 helices. How do ML interactions with these Q1 domains
lead to its activator effect?
As shown in Fig. 1 A (right panel), ML increased the Q1
current amplitude at the plateau voltage of Q1’s activation
curve, indicating that ML’s current-enhancing effect was
independent of its gating-modifying effects. To probe theA
D
B
FIGURE 7 ML and E1 restrict Q1 pore dimension and optimize Kþ conductan
ML, and Q1/E1 expressed in oocytes. Currents were recorded at 80 mVafter a
or 98 mM Rbþ (magenta) as the main cations. Bottom: summary of the Rbþ
(80  EK)], where IRb and ERb are the peak tail current amplitude and revers
98 mM Kþ. ***p < 0.001. (B) Top: pore radii of KcsA crystal structure (PDB ID
astava and Sansom (30)). Middle: average pore radii of Q1 alone or Q1 with four
tom: average pore radii of Q1 alone or Q1/E1 (reproduced from Xu et al. (9)). Zer
(TVGYG of KcsA, TIGYG of Q1). S1–S4: four Kþ binding sites in the selectiv
indicate narrow regions in the averaged Q1 pore dimensions. (C) Pore domain s
diagonal Q1 subunits are shown (gold ribbons). Purple spheres, Kþ ions. (D) C
Biophysical Journal 108(1) 62–75mechanism, we quantified the effect of ML on the Rbþ to
Kþ conductance ratio (GRb/GK) of the Q1 pore. The GRb/
GK value is a simple yet sensitive test of whether the confor-
mation of a K channel’s selectivity filter is perturbed by an
intervention or not (17,27,28). Fig. 7 A shows that the GRb/
GK value of the Q1 pore is 3.25 5 0.18. ML reduced the
GRb/GK value to 0.67 5 0.07, similar to the effect of E1
(the GRb/GK value of Q1/E1 pore was 0.91 5 0.03).
To deduce the structural basis for the effects of ML and E1
on the GRb/GK value of Q1 pore, we used the programHOLE
(29) to quantify the Q1 pore radii in four different states: Q1
alone, Q1 with ML docked to R1 or R2, and Q1 associated
with E1. The Q1 pore radii averaged from snapshots during
the 50–100 ns period of the respective MD trajectories are
plotted against the pore axis in Fig. 7 B (middle and lower
panels). Snapshots of the Q1 pores in the four states are
shown in Fig. 7 C for illustration. For reference, we alsoC
ce. (A) Top: representative tail current traces of Q1, Q1 treated with 25 mM
2 s pulse to þ60 mV. The bath solution contained 98 mM Kþ (black traces)
to Kþ conductance ratio (GRb/GK), calculated as [IRb/(80  ERb)]/[IK/
al potential in 98 mM Rbþ, and IK and EK are the corresponding values in
: 1K4C) and KcsA snapshot during MD simulations (modified from Shriv-
ML molecules in region 1 or region 2 (Q1_ML_R1 and Q1_ML_R2). Bot-
o on the pore axis represents the Ca position of Thr in the signature sequence
ity filter of KcsA crystal structure. Arrows in the middle and bottom panels
napshots of Q1, Q1_ML_R1, Q1_ML_R2, and Q1/E1. For clarity, only two
artoon of working hypothesis (details in text).
A B
FIGURE 8 (A and B) Effects of ML on gating kinetics of Q1 expressed in
oocytes (A) or COS-7 cells (B). In all panels, control data are shown in gray
and data in ML are shown in black. Top: time constant (t) of deactivation
plotted on a logarithmic scale against repolarizing voltage. Tail currents
after the initial hooked phase were fit with a single-exponential function.
Inset: tail currents at80 mVas open circles superimposed on single-expo-
nential fit. Bottom: t of activation plotted on a logarithmic scale against
depolarizing voltage. The activation phase of Q1 was fit with a single-expo-
nential (oocyte) or double-exponential (COS-7) function with sigmoidal
delay. Inset: current at þ20 mV as open circles superimposed on single-
or double-exponential fit. Enlarged views of the gray-shaded areas highlight
ML-enhanced sigmoidal delay in Q1 activation (arrows).
Allostery of ML277’s Action on IKs 71applied the same analysis to the pores of KcsA crystal
structure and a KcsA snapshot during the MD trajectory
(modified from Shrivastava and Sansom (30); Fig. 7 B, top
panel). The pore axis was aligned by zeroing the Ca positions
of Thr in the signature sequences (TVGYG for KcsA, and
TIGYG for Q1).
The pore in the KcsA crystal structure has four narrow re-
gions corresponding to four Kþ binding sites (S1–S4) with
approximately equal occupancies by two Kþ ions in the S1-
S3 or S2-S4 configuration (31). The pore in the KcsA snap-
shot has two narrow regions reflecting two Kþ ions in the
S2–S4 configuration at themomentwhen the snapshotwas re-
corded. TheQ1 pore had only one narrow region, correspond-
ing to the S1/S2 site inKcsA.ML docking to the R1 or R2 site
of Q1, and E1 association with Q1 restricted the inner portion
of the Q1 selectivity filter so that it could coordinate a second
Kþ ion at the S3/S4 position. We quantified the average Kþ
ion occupancy in the selectivity filter during MD trajectories.
Fig. S6 shows that, on average, the inner portion of the Q1
selectivity filter (0–4 A˚ along the pore axis) had a lower Kþ
occupancy in the ML-free state than in ML-bound states.
Fig. 7 D depicts our working hypothesis for how ML and
E1 increase the Q1 pore conductance to Kþ ions while
reducing the GRb/GK value. When K
þ is the charge carrier,
the inner portion of the Q1 selectivity filter is too wide to
effectively coordinate the Kþ ion. As a result, the Q1 pore
frequently enters a nonconducting state (single-channel
flickering) (28) and has a small single-channel conductance,
estimated to be 0.7 pS in physiological [Kþ] (32). When
Rbþ is the charge carrier, its larger ionic radius relative to
the Kþ ion (1.63 vs. 1.49 A˚) allows it to be better coordi-
nated by the inner portion of the Q1 selectivity filter. This
reduces the degree of single-channel flickering and produces
theR3 GRb/GK value observed experimentally (28). When
Q1 is associated with E1, E1’s extracellular domain inter-
acts with the extracellular linkers flanking Q1’s pore loop,
and E1’s TM helix interacts with Q1’s S6 helix (9). These
intimate interactions between E1 and the pore domain
(PD) of Q1 likely restrict the backbone flexibility of Q1’s
selectivity filter, reducing single-channel flickering (28)
and increasing the pore conductance to Kþ ions (32,33).
In the presence of E1, Rb’s larger size does not confer
an advantage in ion conduction through the Q1 pore. The
GRb/GK value of the Q1/E1 pore drops to ~1. We propose
that ML binding to the cleft space between Q1 subunits
likely exerts a similar allosteric effect on the Q1 pore, lead-
ing to an increase in Kþ conductance and a reduction in the
GRb/GK value.Probing the structural basis for ML’s action:
gating modification
In both oocyte and COS-7 expression systems, ML mark-
edly slowed Q1 deactivation and exaggerated the sigmoidal
delay in Q1 activation (Fig. 8). These effects are similar tothe gating-modifying effects of E1 (1,17). To seek the struc-
tural basis for the gating-modifying effects of ML, using E1
as a reference, we used principal component analysis (PCA)
to probe conformational changes in the Q1 backbone
induced by ML or E1 binding (34). In this approach, a
covariance matrix of Q1 Ca atoms is first constructed based
on snapshots during MD trajectories. The matrix is diago-
nalized to separate the Ca movements into components
based on eigenvectors (directions of the movements). The
components are ranked by the associated eigenvalues (mag-
nitudes of the movements). Studies have shown that the first
few principal components with the largest magnitudes of
movements are functionally important, whereas the remain-
ing components of small magnitudes may reflect thermal
motions with little functional consequences (35). When
PCA is applied to combined MD trajectories of ligand-
free and ligand-bound states, the first and largest principal
component reveals the most significant backbone move-
ments induced by ligand binding. Therefore, we combinedBiophysical Journal 108(1) 62–75
72 Xu et al.the 50–100 ns MD trajectories of Q1 alone with ML-bound
or E1-bound Q1. These combined MD trajectories are de-
noted as Q1þQ1_ML_R1, Q1þQ1_ML_R2, and Q1þQ1/
E1. A potential issue with such an analysis is the contribu-
tion of intrinsic dynamics of protein conformation to the
calculated Ca displacements. Therefore, as a control, we
applied PCA to two single MD trajectories: Q1 and Q1/
E1. Fig. S7 shows that the values of the total variance of
Ca motions calculated from single MD trajectories were
much lower than those calculated from combined MD tra-
jectories, supporting the notion that ligand-binding induced
conformational changes were much larger than intrinsic
thermal motions.
The first principal components of Ca displacements
calculated for these five systems are plotted against the
Q1 position numbers in Fig. 9 A. Q1 and Q1/E1 by them-
selves manifested only small degrees of Ca displacements
mainly in the loop regions flanking transmembrane helices.
These small Ca movements likely reflect random fluctua-
tions of the Q1 conformation around the equilibrium state.
On the other hand, the Ca displacements calculated for the
three combined MD trajectories were much larger, and
occurred in not only the loop regions but also the transmem-
brane helices. The quantitative and qualitative differences
between these two sets of data support the notion that theVS
B
S1 S2 S3 S4 S5 S6P
Q1 position number
Fi
rs
t p
rin
ci
pa
l c
om
po
ne
nt
 o
f Q
1 
C
α
di
sp
la
ce
m
en
t (
Å
)
A
Q1
Q1 + Q1/E1
0
2
4
6
0
2
4
6
0
2
4
6
0
2
4
6
150 200 250 300 350
0
2
4
6
Q1/E1
Q1 + Q1_ML_R1
Q1 + Q1_ML_R2
FIGURE 9 PCA of Q1 backbone movements associated with ML or E1 bind
calculated from single MD trajectories of Q1 and Q1/E1, and from combined
The values of Ca displacements in the four Q1 subunits are averaged and plotted
helices (S1–S6) and P loop are highlighted by gray shading. Horizontal bars along
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Biophysical Journal 108(1) 62–75Ca displacements in the latter case reflect changes in the
Q1 backbone conformation induced by ML or E1 binding.
Fig. 9 B compares the directions andmagnitudes of Ca dis-
placements in Q1 backbone induced by ML and E1 binding.
We use green-white-red lines to connect Ca positions in Q1
alone (green) and in ML- or E1-bound Q1 (red). Therefore,
thegreen-to-red color transition and the length of the line indi-
cate the direction andmagnitude, respectively, of Ca displace-
ments induced byML or E1 binding. The views in Fig. 9B are
from the intracellular side, showing that ML and E1 binding
induced similar rotations of the Q1 gating apparatus: the
S2-S3 loops and S4-S5 linkers in the voltage-sensing domain
(VSD), and the carboxyl termini of S6 (S6CT) in the PD. Pre-
vious studies have shown that E1 directly interacts with the
S4-S5 linker and S6CT of the Q1 channel (9,36), and these
interactions may reduce the coupling efficiency between the
voltage sensor movement and the S6 bundle-crossing gate
(37). We propose that ML binding to the cleft space between
Q1 subunits can induce similar effects and slows both activa-
tion and deactivation transitions in the Q1 channel.Comparison with previous studies
Q1 is the first of a five-member KCNQ channel family.
Whereas Q1 is mainly expressed in peripheral nonneuronalE1
E1
Q1
Q1 + Q1_ML_R1 Q1 + Q1_ML_R2
Q1 + Q1/E1
S2-S3
S4-S5
S6CT
PD
D
ing. (A) Top to bottom: first principal component of Q1 Ca displacements
MD trajectories of Q1þQ1_ML_R1, Q1þQ1_ML_R2, and Q1þQ1/E1.
as mean with SE bar against the Q1 position number. The transmembrane
the abscissa denote the three regions highlighted in B. (B) Intracellular side
oop, S4-S5 helix, and S6CT marked by green-white-red lines. A green-to-red
the magnitude of movement. Yellow and orange arrows indicate the general
e marked in the Q1 panel. The approximate E1 positions are indicated by
Allostery of ML277’s Action on IKs 73cell types, KCNQ2–KCNQ5 (Q2–Q5) are expressed exclu-
sively in neurons. A large number of small-molecule activa-
tors of the KCNQ channels have been reported (4). Q1
activators can be used to treat LQT syndromes, and activa-
tors of the neuronal KCNQ channels are designed to treat
epilepsy and pain.
Q1 and Q2 are homologous in the S1–S6 region (60.2%
identity). Why is ML active on Q1 but>100-fold less active
on Q2 (7)? The amino acid sequence alignment shown in
Fig. 10 (top) indicates that all but two of the Q1 residues
predicted to be important for ML binding are conserved in
Q2. The Q2 residues equivalent to F275 and F335 in Q1
are L245 and L330, respectively. Ala substitution at either
position in Q1 greatly reduced ML’s current-enhancing ef-
fect (Fig. 5) due to a disruption of p-p interactions between
the two aromatic rings and the ML molecule. Loss of these
two aromatic rings in Q2 may explain the much lower
potency of ML in increasing the Q2 current amplitude.
How does the ML binding space described here compare
with the binding sites described for the other KCNQ activa-
tors? Fig. 10 shows that the ML binding space is indepen-
dent of the binding pockets for NH29 (38), ztz240 (39),
and thimerosal (TMS) (40). All three molecules bind to
the VSD of their target KCNQ channels from the extracel-
lular side of the membrane. Although the ML binding space
includes the retigabine binding site on the S6 helix of Q2 (4)
(as shown in Fig. 10), it does not include the retigabine
binding site on the S5 helix of Q2, W236, which is abso-
lutely required for retigabine’s activator effect (not shown
in the perspective of Fig. 10).
The ML binding space overlaps extensively with residues
that are important for the activator effects of R-L3 (41) and
ZnPy (42,43). These three KCNQ activators also have
similar activator effects: 1), they all increase the Q1 current
amplitudes independently of their gating-modifying effects; 2), they all slow Q1 deactivation and activation; and 3), their
current-enhancing effects on Q1 are reduced by E1 associa-
tion (41,42). Furthermore, ZnPy’s activator effect on Q3 is
enhanced by PIP2 depletion (44), similar to ML’s activator
effect on Q1 (Fig. 6). We suggest that ML, R-L3, and
ZnPy bind to side pockets between Q1 subunits, increasing
the pore conductance and hindering gating transitions by the
same or similar mechanisms.CONCLUSIONS
The combination of computational modeling and experi-
mental validation offers important advantages over the
candidate drug-binding site approach. In the latter case,
scanning mutagenesis is applied to the presumed drug-bind-
ing region, and the impact of mutations on drug effects is in-
terpreted as a disruption or enhancement of drug binding to
the presumed binding site. Our results suggest that ML can
dynamically interact with Q1 residues over a relatively large
range, from a hydrophilic/charged environment exposed to
the intracellular solution to a hydrophobic pocket between
transmembrane helices. Importantly, our models suggest
that ML increases the Q1 current amplitude and affects
Q1 gating kinetics by allosteric mechanisms.SUPPORTING MATERIAL
SupportingMaterials andMethods, sevenfigures, one table, and onemovie are
available at http://www.biophysj.org/biophysj/supplemental/S0006-3495(14)
01148-5.
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Heart Association/Mid-Atlantic Affiliate to Y.X.FIGURE 10 Comparison of the ML binding
site with those of other KCNQ activators.
Top: sequence alignment between (KCN)Q1 and
(KCN)Q2 in S2–S6 helices and the P loop. Color
shading highlights equivalent Q1 and Q2 residues
that are important for the effects of NH29 (blue),
TMS (cyan), ztz240 (green), R-L3 (pink), ZnPy
(purple), and retigabine (red). Center: side view
of a partial Q1 homology model, showing helices
involved in drug binding (S2–S5 of one subunit
and S5-S6 of an adjacent subunit). Golden mesh,
ML binding space; colored spheres, residues high-
lighted in the sequence alignment. Left and right:
structures of KCNQ activators. Atom colors: car-
bon, gray; nitrogen, blue; oxygen, red; hydrogen,
white; sulfur, yellow; Hg, cyan; Zn, olive green;
Cl, green; F, light blue.
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